- Paul Kiesel | July 07, 2009 5:49 PM | Los Angeles, CA
Category:
FDA & Prescription Drugs
From the Associated Press:
NEW YORK (AP) — Shares of Matrixx Initiatives Inc. fell Monday after the company disclosed several class action lawsuits related to its withdrawn cold treatment...
- Paul Kiesel | July 02, 2009 2:25 PM | Los Angeles, CA
Category:
FDA & Prescription Drugs
From The Atlantic:
I missed commenting on this earlier, but many readers may have noticed the recent scandal caused by Zicam. This is a cold remedy which was sold as a homeopathic medicine, but its...
- Paul Kiesel | June 29, 2009 4:41 PM | Los Angeles, CA
Category:
FDA & Prescription Drugs
From The New York Times:
WHEN it comes to corporate America, critics and skeptics are about as welcome as skunks at a pool party. And when companies try to silence dissenters, shareholders are...